According to the American Academy of Pediatrics' 2023 guidelines, adolescents must have an initial BMI at or above the 95th percentile (corresponding to obesity) to qualify for pharmacotherapy
Rather than needing an ideal 8-hour overnight window, these workers can potentially improve the restorative value of the sleep they do get
CVS Caremark drops coverage of popular weight loss drug Medical experts warn insurance decisions are overriding doctor recommendations and disrupting patient progress CVS Caremark, one of the three major pharmacy benefit managers (PBM) in the U.S., stopped coverage for Eli Lilly's popular weight-loss drug Zepbound, blaming drugs like it for driving up overall plan costs
Note: an older GLP-1, liraglutide (Saxenda) , is also approved for weight management but is being discontinued as newer options take over
See pricing, medications, doctor access, and coaching to find your best fit